Search

Your search keyword '"Rawal, Sahil"' showing total 10 results
Start Over Author "Rawal, Sahil" Search Limiters Available in Library Collection
10 results on '"Rawal, Sahil"'

1. Abstract 15514: Ace Inhibitors, Angiotensin Receptor Blockers, and Outcomes in Hospitalized Patients With Severe Covid-19 Pneumonia

Author

Grewal, Prabhjot, Yoo, Jeanwoo, Papamanoli, Aikaterini, Mojahedi, Azad, Dhaliwal, Simrat, Nakamura, Jacquelyn, Abata, Joshua, Robin, Jacob, Fung, Jenny, Hotelling, Jessica, Rawal, Sahil, Karkala, Nikitha, Tsui, Stella T, Coritsidis, Alexandra, Marcos, Luis, Bloom, Michelle E, Skopicki, Hal, and Kalogeropoulos, Andreas P

Published
2020
Full Text
View/download PDF

4. 76. Effect of Early Administration of Systemic Corticosteroids on Outcomes in Patients with COVID-19 Pneumonia

Author

Papamanoli, Aikaterini, primary, Kalogeropoulos, Andreas, additional, Fung, Jenny, additional, Nakamura, Jacquelyn, additional, Yoo, Jeanwoo, additional, Grewal, Prabhjot, additional, Karkala, Nikitha, additional, Abata, Joshua, additional, Tsui, Stella T, additional, Coritsidis, Alexandra, additional, Mojahedi, Azad, additional, Jacob, Robin, additional, Hotelling, Jessica, additional, Dhaliwal, Simrat, additional, Rawal, Sahil, additional, and Marcos, Luis, additional

Published
2020
Full Text
View/download PDF

5. 53. Incidence of Bloodstream Infections and Outcomes in Patients with Severe COVID-19 Pneumonia

Author

Papamanoli, Aikaterini, primary, Yoo, Jeanwoo, additional, Mojahedi, Azad, additional, Jacob, Robin, additional, Grewal, Prabhjot, additional, Dhaliwal, Simrat, additional, Coritsidis, Alexandra, additional, Nakamura, Jacquelyn, additional, Fung, Jenny, additional, Hotelling, Jessica, additional, Rawal, Sahil, additional, Karkala, Nikitha, additional, Tsui, Stella T, additional, Abata, Joshua, additional, Psevdos, George, additional, Kalogeropoulos, Andreas, additional, and Marcos, Luis, additional

Published
2020
Full Text
View/download PDF

6. 382. Incidence of Hospital-Acquired and Ventilator-Associated Pneumonia in Patients with Severe COVID 19 on High Flow Oxygen

Author

Papamanoli, Aikaterini, primary, Nakamura, Jacquelyn, additional, Fung, Jenny, additional, Abata, Joshua, additional, Karkala, Nikitha, additional, Tsui, Stella T, additional, Yoo, Jeanwoo, additional, Grewal, Prabhjot, additional, Mojahedi, Azad, additional, Dhaliwal, Simrat, additional, Jacob, Robin, additional, Hotelling, Jessica, additional, Rawal, Sahil, additional, Coritsidis, Alexandra, additional, Psevdos, George, additional, Kalogeropoulos, Andreas, additional, and Marcos, Luis, additional

Published
2020
Full Text
View/download PDF

7. Abstract 359: Unit-Specific Influences on Conscious Sedation Nursing Practices: Comparing Medication Utilization and Patient Outcomes

Author

Parone, Linda, primary, Rawal, Sahil, additional, Ellis, Allison, additional, Peterson, Bryant, additional, Escalante, Lourdes, additional, Sharma, Ravi, additional, Pandya, Bhavi, additional, Kumar, Arnav, additional, Panchal, Hemang B, additional, Prakash, Meghanaprakash H, additional, Yadav, Ritu, additional, Kanwar, Nidhi, additional, and Sawant, Abhishek, additional

Published
2020
Full Text
View/download PDF

10. Abstract 10046: Elevated Serum St2 is Associated With Higher Hospitalization Rates in Caucasian and African-American Outpatients With Stage C Heart Failure

Author

Savvoulidis, Panagiotis, Snider, James, Rawal, Sahil, Morris, Alanna, Butler, Javed, Georgiopoulou, Vasiliki, and Kalogeropoulos, Andreas P

Abstract

Introduction:Limited data exist on the association between suppression of tumorigenicity 2 (ST2) levels and recurrent hospitalizations and emergency department (ED) visits in ambulatory patients with heart failure (HF). In addition, race-specific data are scarce.Hypothesis:To evaluate the association of ST2 with (1) all-cause, cardiovascular, and HF-related hospitalization and ED visit rates and (2) death or HF hospitalization in outpatients with HF in a racially diverse population.Methods:We evaluated 307 outpatients with HF participating in a prospective cohort study in Atlanta, GA. ST2 was measured with a commercially available ELISA. Median follow-up was 3.1 years.Results:Mean age was 57?12 years, 64.2% were men, 51.5% Caucasian and 45.6% African-American, 26.7% in NYHA class III-IV. Median ejection fraction (EF) was 35% (60.3% had EF <40%); median BNP was 162 ng/mL; 41.4% had ischemic heart disease, and 33.6% had diabetes. Elevated (>35 ng/mL) ST2 was associated with 1.5- to 4-fold higher recurrent event rates, driven by HF events, Table 1. ST2 >35 ng/mL was associated with higher risk for death or HF hospitalization, met by 109 patients (3-year estimate: 35.4%; 44 deaths, 7 transplants, 4 ventricular assist devices, and 54 HF admissions); the adjusted HR was 2.28; 95%CI 1.38 to 3.78; P=0.001), Fig. 1. The risk was 5-fold higher in the first 6 months but declined gradually. There was no interaction between ST2 and gender or race for outcomes.Conclusions:Elevated ST2 levels among outpatients with HF are associated with 2-fold higher risk for death or HF hospitalization, which is higher in the first 6 months, and more healthcare resources utilization regardless of gender or race.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results